Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentro Cardiologico Monzino

About this trial

This is a multicenter prospective collection of data with diagnostic procedures different from standard clinical care in a specific cohort of patients, aimed to evaluate cardiovascular risk stratification with the European Society of Cardiology (ESC)/European Association for the Study of Diabetes (EASD) guidelines and "The Steno Type 1 Risk Engine" algorithm. The correlation between CVD risk, atherosclerosis, and microvascular complications of diabetes (retinopathy, nephropathy, and neuropathy) will then be evaluated, and the impact of glycemic variability and other glucose metrics on vascular damage will be characterized. The investigators plan to enroll at least 200 consecutive type 1 diabetes mellitus (T1DM) patients who meet all the inclusion criteria and none of exclusion criteria.

Eligibility criteria

Qualifiers

Diagnosis of type 1 diabetes mellitus.

Age ≥ 18 years.

Signed Informed consent

Disqualifiers

Age < 18 years.

Pregnancy in progress.

Type 2 diabetes mellitus.

Secondary diabetes

Trial design

Treatments tested in this trial

  • Standard of care plus additional examinations

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators